Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 9.0B | 11.5B | 9.7B | 10.8B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | 8.8B | 10.6B | 8.8B | 10.1B |
| Operating income | -49M | 562M | 587M | 460M |
| Non operating interest income | ||||
| Income | 43M | 38M | 47M | 39M |
| Expense | 21M | 29M | 21M | 21M |
| Other income expense | — | — | — | — |
| Pretax income | -21M | 558M | 616M | 484M |
| Tax provision | -5M | 83M | 135M | 106M |
| Net income | -17M | 475M | 480M | 377M |
| Basic EPS | -0.2 | 3.2 | 3.4 | 2.7 |
| Diluted EPS | -0.2 | 3.2 | 3.4 | 2.7 |
| Basic average shares | 105M | 134.4M | 136.8M | 132.6M |
| Diluted average shares | 105M | 134.4M | 136.8M | 132.6M |
| EBITDA | 262M | 953M | 899M | 763M |
| Net income from continuing op. | -21M | 558M | 616M | 484M |
| Minority interests | -4M | -45M | -15M | -19M |
| Preferred stock dividends | 0 | 0 | 0 | 0 |